David A. Dresner
2017
In 2017, David A. Dresner earned a total compensation of $203.9K as Former Interim President and Chief Executive Officer at Osiris Therapeutics, a 9% decrease compared to previous year.
Compensation breakdown
| Bonus | $30,000 |
|---|---|
| Salary | $173,115 |
| Other | $834 |
| Total | $203,949 |
Dresner received $173.1K in salary, accounting for 85% of the total pay in 2017.
Dresner also received $30K in bonus and $834 in other compensation.
Rankings
In 2017, David A. Dresner's compensation ranked 14,010th out of 14,666 executives tracked by ExecPay. In other words, Dresner earned more than 4.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 14,010 out of 14,666 | 5th |
Division Manufacturing | 5,493 out of 5,768 | 5th |
Major group Chemicals And Allied Products | 1,971 out of 2,074 | 5th |
Industry group Drugs | 1,643 out of 1,730 | 5th |
Industry Biological Products, Except Diagnostic Substances | 306 out of 316 | 3rd |
Source: SEC filing on May 11, 2018.
Dresner's colleagues
We found six more compensation records of executives who worked with David A. Dresner at Osiris Therapeutics in 2017.
2017
Alla Danilkovitch
Osiris Therapeutics
Chief Scientific Officer
2017
Jason Keefer
Osiris Therapeutics
Chief Executive Officer
2017
Linda Palczuk
Osiris Therapeutics
Chief Executive Officer
2017
Linda Chang
Osiris Therapeutics
Chief Financial Officer
2017
Gregory Law
Osiris Therapeutics
Chief Financial Officer
2017
R Avendano
Osiris Therapeutics